Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Crystallization (Commentary)

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search

Search term:

Results 1 - 4 of 4
EC Number Crystallization (Commentary)
Display the word mapDisplay the reaction diagram Show all sequences 1.14.11.29isoform PHD2 in complex with Mn2+, sitting drop vapor diffusion method, using 1.6 M sodium citrate/citric acid pH 6.5
Display the word mapDisplay the reaction diagram Show all sequences 1.14.11.29L-ascorbic acid can be docked in the binding site of 2-oxoglutarate and may chelate the iron ion, D-ascorbate cannot be docked
Display the word mapDisplay the reaction diagram Show all sequences 1.14.11.29sitting-drop vapor-diffusion method, the crystal structure reveals an EF domain with two Ca2+-binding motifs inserted within the catalytic domain. A substrate-binding groove is formed between the EF domain and the conserved core of the catalytic domain
Display the word mapDisplay the reaction diagram Show all sequences 1.14.11.29structure of a truncated domain of PHD2 with MnII substituting for FeII and complexed with inhibitor 4-hydroxy-N-[(4-phenoxyphenyl)methyl]-2-(1H-pyrazol-1-yl)pyrimidine-5-carboxamide reveals a binding mode involving chelation of the active site metal via nitrogen atoms of the pyrazolo and a pyrimidyl rings which adopt a coplanar conformation. The pyrazole ring of the inhibitor occupies the entrance of the active site pocket that is occupied by the CH2CO2H group of 2-oxoglutarate during catalysis
Results 1 - 4 of 4